Loading…
Based on limited metadata, this warning letter was issued to GOJO Industries Inc., a company involved in drug product manufacturing or distribution, on January 17, 2020. Without access to the full letter text or subject line, the specific violations cannot be determined from the available information. The warning falls under FDA drug product regulation, though the specific issuing office and violation count are not documented in this metadata summary.